bpc 157 safe clinical evidence bpc-157 safety What is BPC-157? The Benefits,

[21] When treated with cyanocobalamin, patients with Leber's disease may develop serious optic atrophy, possibly leading to blindness, based on few case reports

The threshold at which this association has been observed is serum levels over 813 pg/mL (600 pmol/L)

A contaminated or improperly preserved diluent undermines even the highest-purity peptide

PNC-27 and Specific Cancer Cell Lines PNC-27 might selectively target specific forms of leukemia cells and induce necrosis, particularly those displaying high levels of HDM-2 on their membranes

Though research has not identified increased cancer risk, and some studies suggest BPC-157 may actually have anti-tumor properties, patients with cancer history should discuss use with their oncologist